108 related articles for article (PubMed ID: 22021908)
21. Effects of hepatitis B virus X protein on the development of liver cancer.
Zhang X; Zhang H; Ye L
J Lab Clin Med; 2006 Feb; 147(2):58-66. PubMed ID: 16459163
[TBL] [Abstract][Full Text] [Related]
22. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
[TBL] [Abstract][Full Text] [Related]
23. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
[TBL] [Abstract][Full Text] [Related]
24. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
25. Transgenic mouse models of hepatitis B virus-associated hepatocellular carcinoma.
Singh M; Kumar V
Rev Med Virol; 2003; 13(4):243-53. PubMed ID: 12820186
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel regulators associated with early-phase osteoblast differentiation.
de Jong DS; Vaes BL; Dechering KJ; Feijen A; Hendriks JM; Wehrens R; Mummery CL; van Zoelen EJ; Olijve W; Steegenga WT
J Bone Miner Res; 2004 Jun; 19(6):947-58. PubMed ID: 15125793
[TBL] [Abstract][Full Text] [Related]
27. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
29. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
[TBL] [Abstract][Full Text] [Related]
30. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.
Terradillos O; Pollicino T; Lecoeur H; Tripodi M; Gougeon ML; Tiollais P; Buendia MA
Oncogene; 1998 Oct; 17(16):2115-23. PubMed ID: 9798683
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
32. Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo.
Li CH; Wang YJ; Dong W; Xiang S; Liang HF; Wang HY; Dong HH; Chen L; Chen XP
Cancer Lett; 2011 Dec; 311(1):1-10. PubMed ID: 21821357
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
34. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
35. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
37. Mouse models to study the interaction of risk factors for human liver cancer.
Sell S
Cancer Res; 2003 Nov; 63(22):7553-62. PubMed ID: 14633666
[TBL] [Abstract][Full Text] [Related]
38. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
39. Integrative genomics based identification of potential human hepatocarcinogenesis-associated cell cycle regulators: RHAMM as an example.
Yang CW; Su JY; Tsou AP; Chau GY; Liu HL; Chen CH; Chien CY; Chou CK
Biochem Biophys Res Commun; 2005 May; 330(2):489-97. PubMed ID: 15796909
[TBL] [Abstract][Full Text] [Related]
40. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
